Provided by Tiger Trade Technology Pte. Ltd.

Biohaven Pharmaceutical Holding Co Ltd.

14.38
+0.70005.12%
Post-market: 14.420.0400+0.28%19:36 EDT
Volume:3.44M
Turnover:49.58M
Market Cap:2.16B
PE:-3.21
High:14.86
Open:13.96
Low:13.92
Close:13.68
52wk High:18.57
52wk Low:7.48
Shares:150.42M
Float Shares:117.99M
Volume Ratio:1.51
T/O Rate:2.92%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.4800
EPS(LYR):-6.8648
ROE:-799.46%
ROA:-71.98%
PB:176.98
PE(LYR):-2.09

Loading ...

Biohaven Receives Favorable Ruling in the Trade Secret Misappropriation Lawsuit

MT Newswires Live
·
6 hours ago

Biohaven - Federal Court Confirms Ra Capital and Avilar Therapeutics "Misappropriated" Yale Trade Secret

THOMSON REUTERS
·
7 hours ago

Biohaven - U.S. District Court Awards $4 Mln to Biohaven and Yale in Trade Secret Case

THOMSON REUTERS
·
7 hours ago

Biohaven Files Form 3 Initial Beneficial Ownership Statement for Director John Yetimoglu

Reuters
·
Aug 15

Biohaven Supported by Multiple Pipeline Catalysts, Cash Runway Into 2027, RBC Says

MT Newswires Live
·
Aug 11

RBC Adjusts Price Target on Biohaven to $23 From $22, Maintains Outperform Speculative Risk Rating

MT Newswires Live
·
Aug 11

Bank of America Securities Reaffirms Their Buy Rating on Biohaven Ltd. (BHVN)

TIPRANKS
·
Aug 11

Analysts Offer Insights on Healthcare Companies: Arcutis Biotherapeutics (ARQT) and Biohaven Ltd. (BHVN)

TIPRANKS
·
Aug 11

Biohaven Q2 Adj. EPS $(0.78) Misses $(0.73) Estimate

Benzinga Earnings
·
Aug 11

Biohaven Ltd. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 11

Biohaven Q2 Adjusted Loss Narrows

MT Newswires Live
·
Aug 11

Biohaven Q2 Net Loss Narrows on Lower R&D Spend

Reuters
·
Aug 11

Biohaven Q2 FY26 Net Loss Narrows 30.7% to $137.31 Million; R&D Expenses Fall 45.34% to $100.81 Million

Reuters
·
Aug 11

Biohaven Q2 Basic EPS USD -0.91

THOMSON REUTERS
·
Aug 11

Biohaven Appoints John Yetimoglu to Board

Reuters
·
Aug 08

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Jul 31

How Biohaven’s (BHVN) Trade Secret Verdict Shapes Its Intellectual Property Defense Strategy

Simply Wall St.
·
Jul 28

Biohaven Awarded $1 Million Over Alleged Trade Secret Violations by Avilar Therapeutics, RA Capital Management

MT Newswires Live
·
Jul 27

Biohaven, Yale Win USD 4 Million Jury Verdict over MODA Trade Secret Theft

Reuters
·
Jul 27

Biohaven reports new data on BHV-1530

TIPRANKS
·
Jul 20